DZ Bank Call 20 SFQ 20.09.2024/ DE000DJ65QA9 /
| 2024-05-23 9:34:54 PM | Chg.-0.020 | Bid9:59:53 PM | Ask9:59:53 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.330EUR | -5.71% | 0.330 Bid Size: 1,250 |
0.510 Ask Size: 1,250 |
SAF-HOLLAND SE INH ... | 20.00 EUR | 2024-09-20 | Call |
GlobeNewswire
11:04 PM
Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire
11:03 PM
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
GlobeNewswire
11:01 PM
Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire
11:01 PM
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
11:01 PM
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire
11:00 PM
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
GlobeNewswire
11:00 PM
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire
11:00 PM
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
11:00 PM
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire
11:00 PM
MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire
11:00 PM
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire
11:00 PM
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
11:00 PM
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
11:00 PM
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire
11:00 PM
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology A...
GlobeNewswire
11:00 PM
Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monothera...
GlobeNewswire
11:00 PM
IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2...
GlobeNewswire
11:00 PM
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 ...
GlobeNewswire
11:00 PM
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head a...
GlobeNewswire
11:00 PM
Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at ...
GlobeNewswire
10:55 PM
Park Aerospace Corp. Announces Date of Fiscal Year Earnings Release and Conference Call
GlobeNewswire
10:49 PM
THOR Industries Announces Date For Its Fiscal 2024 Third Quarter Earnings Release
